tirzepatide hearing loss Risk of peripheral vestibular disorders and impairment among users of glucagon-like peptide-1 receptor agonists Does Tepezza Cause Hearing Loss?

The rationale is straightforward: tirzepatide activates GIP receptors that liraglutide does not touch, so your body needs time to adjust to the new mechanism

TeleHealth Med's injection guide recommends rotating between the abdomen, front or outer thigh, and upper arm

Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), and is not approved for use in children or adolescents under 18 years of age

However, the better medication for an individual depends on more than average weight loss

doi: 10.1038/s41467-018-04467-3

However, as with any medication, individual health state, existing medical conditions, and potential for side effects should be taken into account